Stage IIIC Cutaneous Melanoma AJCC v7 Active Not Recruiting Phase 1 Trials for Riluzole (DB00740)

IndicationStatusPhase
DBCOND0091049 (Stage IIIC Cutaneous Melanoma AJCC v7)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01303341Riluzole and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors or MelanomaTreatment